Follow
Anders Gaarsdal Holst
Anders Gaarsdal Holst
Acesion Pharma and Department of Cardiology, University Hospital Rigshospitalet
Verified email at kanten.dk
Title
Cited by
Cited by
Year
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes
SP Marso, SC Bain, A Consoli, FG Eliaschewitz, E Jódar, LA Leiter, ...
New England Journal of Medicine 375 (19), 1834-1844, 2016
57072016
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology
JB Nielsen, RB Thorolfsdottir, LG Fritsche, W Zhou, MW Skov, SE Graham, ...
Nature genetics 50 (9), 1234-1239, 2018
6692018
Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial
AJ Ahmann, M Capehorn, G Charpentier, F Dotta, E Henkel, I Lingvay, ...
Diabetes care 41 (2), 258-266, 2018
5122018
Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study
AG Holst, G Jensen, E Prescott
Circulation 121 (17), 1896-1903, 2010
4922010
Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
J Blundell, G Finlayson, M Axelsen, A Flint, C Gibbons, T Kvist, ...
Diabetes, Obesity and Metabolism 19 (9), 1242-1251, 2017
4672017
Nationwide study of sudden cardiac death in persons aged 1–35 years
BG Winkel, AG Holst, J Theilade, IB Kristensen, JL Thomsen, GL Ottesen, ...
European heart journal 32 (8), 983-990, 2011
4342011
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial
JH Svendsen, SZ Diederichsen, S Højberg, DW Krieger, C Graff, ...
The Lancet 398 (10310), 1507-1516, 2021
3872021
Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study
BE Bussink, AG Holst, L Jespersen, JW Deckers, GB Jensen, E Prescott
European Heart Journal 34 (2), 138-146, 2013
3082013
Incidence and etiology of sports-related sudden cardiac death in Denmark—implications for preparticipation screening
AG Holst, BG Winkel, J Theilade, IB Kristensen, JL Thomsen, GL Ottesen, ...
Heart rhythm 7 (10), 1365-1371, 2010
3042010
Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members
J Saberniak, NE Hasselberg, R Borgquist, PG Platonov, SI Sarvari, ...
European journal of heart failure 16 (12), 1337-1344, 2014
2822014
New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants
C Andreasen, JB Nielsen, L Refsgaard, AG Holst, AH Christensen, ...
European Journal of Human Genetics 21 (9), 918-928, 2013
2392013
P-wave duration and the risk of atrial fibrillation: Results from the Copenhagen ECG Study
JB Nielsen, JT Kühl, A Pietersen, C Graff, B Lind, JJ Struijk, MS Olesen, ...
Heart Rhythm 12 (9), 1887-1895, 2015
2332015
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation
MF Sinner, NR Tucker, KL Lunetta, K Ozaki, JG Smith, S Trompet, JC Bis, ...
Circulation 130 (15), 1225-1235, 2014
2242014
Burden of sudden cardiac death in persons aged 1 to 49 years: nationwide study in Denmark
B Risgaard, BG Winkel, R Jabbari, ER Behr, O Ingemann-Hansen, ...
Circulation: Arrhythmia and Electrophysiology 7 (2), 205-211, 2014
2082014
Semaglutide effects on cardiovascular outcomes in people with overweight or obesity (SELECT) rationale and design
DH Ryan, I Lingvay, HM Colhoun, J Deanfield, SS Emerson, SE Kahn, ...
American heart journal 229, 61-69, 2020
2002020
Epilepsy and risk of death and sudden unexpected death in the young: a nationwide study
AG Holst, BG Winkel, B Risgaard, JB Nielsen, PV Rasmussen, S Haunsø, ...
Epilepsia 54 (9), 1613-1620, 2013
1792013
Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies
BK Mahmoodi, M Cushman, I Anne Næss, MA Allison, WJ Bos, ...
Circulation 135 (1), 7-16, 2017
1732017
Sports-related sudden cardiac death in a competitive and a noncompetitive athlete population aged 12 to 49 years: data from an unselected nationwide study in Denmark
B Risgaard, BG Winkel, R Jabbari, C Glinge, O Ingemann-Hansen, ...
Heart rhythm 11 (10), 1673-1681, 2014
1662014
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
M Husain, SC Bain, OK Jeppesen, I Lingvay, R Sørrig, MB Treppendahl, ...
Diabetes, Obesity and Metabolism 22 (3), 442-451, 2020
1592020
High Prevalence of Long QT Syndrome–Associated SCN5A Variants in Patients With Early-Onset Lone Atrial Fibrillation
MS Olesen, L Yuan, B Liang, AG Holst, N Nielsen, JB Nielsen, PL Hedley, ...
Circulation: Cardiovascular Genetics 5 (4), 450-459, 2012
1532012
The system can't perform the operation now. Try again later.
Articles 1–20